where science meets innovation
WHO WE ARE
KEYMED is a leading independent national research and consulting firm in the healthcare industry. We help clients stay ahead of the curve in private/public funded healthcare by providing technical assistance, resources, decision support and expertise. Whether your project has "run into a snag" or hasn't even gotten off the ground, we can provide the expertise and guidance to help you make it a success.
SERVICES
Advanced Data Analysis
KeyMed consultants are empowered to be able to engage physicians and administrators with compelling, data-driven collateral. Our reports are tailored for physician or facility stakeholders, and generated dynamically by our field representatives. Improve your outreach with KeyMed's high-impact reports.
Analytical Problem Solving
KeyMed's trained consultants deliver actual solutions to the facility or physician driven by accurate data. Our team will provide detailed reports that reveal problems and present appropriate opportunities custom-tailored to your specific profile. Our consultants are more than just sales reps.
Industry Leading Products
Healthcare is constantly evolving due in large part to advances in healthcare products. KeyMed provides clients with access to the latest innovations in healthcare. Where our reps stand apart from other consultants is in providing a detailed strategy and regular reporting on the benefits and/or cons of these new advances.
latest products
Zenith™
Amniotic Membrane Allograft Q4253
Zenith Amniotic Membrane is a sterile allograft designed for optimal wound covering and protection during the treatment of wounds.
Amniotic Key Features and Properties
- Provides a reliable protective wound covering backed by decades of science
- Dehydrated extracellular matrix acts as a scaffold supporting the native tissue
- Adheres easily to wounds including those with irregular surfaces
- Immune privileged and angiogenic
- 5-year shelf life at ambient temperature storage
Zenith is an amniotic membrane allograft derived from a prescreened mother with a planned C-section delivery. Zenith is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. Zenith is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
Impax™
Dual Layer Membrane
Awarded Q Code Q4262 (effective 1/1/23)
Dual Layer Impax Membrane is a sterile allograft designed for optimal wound covering and protection during the treatment of wounds.
Dual Layer Impax Membrane Key Features and Properties
- Provides a protective wound covering
- Dehydrated extracellular matrix acts as a scaffold supporting the native tissue
- Adheres easily to wounds, including those with irregular surfaces
- Immune privileged and angiogenic
- 5-year shelf life at ambient temperature storage
Dual Layer Impax Membrane is an amniotic membrane allograft derived from a prescreened mother with a planned C-section delivery. Dual Layer Impax Membrane is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. Dual Layer Impax Membrane is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
SurGraft FT™
Full Thickness Graft
Awarded Q Code Q4268
SurGraft FT is a sterile full thickness graft designed for optimal wound covering and protection during the treatment of wounds.
SurGraft FT Features and Properties
- Provides a reliable protective wound covering backed by decades of science
- Dehydrated extracellular matrix acts as a scaffold supporting the native tissue
- Adheres easily to wounds including those with irregular surfaces
- Immune privileged and angiogenic
- 5-year shelf life at ambient temperature storage
SurGraft FT full thickness graft is an allograft derived from a prescreened mother with a planned C-section delivery. SurGraft FT is manufactured in compliance with FDA regulations and AATB guidance. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. SurGraft FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.